This application details the experience, qualifications and short- and long-term plans for the patient-oriented research and mentoring activities of Randall F. Holcombe, MD, Chief of Hematology/Oncology at the University of California, Irvine and Associate Director for Clinical Research of the Chao Family Comprehensive Cancer Center. Since completion of Hematology/Oncology sub-specialty training in 1989, Dr. Holcombe has established an academic career in clinical and translational patient-oriented research involving both clinical and basic investigations in the areas of oncology, immunology and genetics. He has been successful in conducting clinical/translational trials and in obtaining extramural support for these activities. Currently and over the past several years, he has also been active in mentoring beginning clinical investigators. This application for the Midcareer Investigator Award in Patient-Oriented Research will provide support to allow Dr. Holcombe to continue and expand upon these activities. This application will outline proposed research and mentoring activities, institutional support for these activities, and documentation of Dr. Holcombe's commitment to a career in patient-oriented research. This is a second revision of a Midcareer Investigator Award in Patient-Oriented Research (K24) initially submitted 10/1/98, with a first revision submitted 7/1/99. Substantial modifications in response to questions raised in the first summary statement were included in the first revision. While minimal criticisms of the proposal were noted in the second summary statement, additional information that further strengthens the application has been provided in preparation of this second revision.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
1K24CA082450-01A2
Application #
6327470
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
2001-04-19
Project End
2006-03-31
Budget Start
2001-04-19
Budget End
2002-03-31
Support Year
1
Fiscal Year
2001
Total Cost
$127,915
Indirect Cost
Name
University of California Irvine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Planutis, Kestutis; Planutiene, Marina; Nguyen, Anthony V et al. (2013) Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment. J Transl Med 11:50
Dellinger, Thanh H; Planutis, Kestutis; Jandial, Danielle D et al. (2012) Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Gynecol Oncol 126:259-67
Najdi, Rani; Holcombe, Randall F; Waterman, Marian L (2011) Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog 10:5
Nguyen, Anthony V; Albers, C Gregory; Holcombe, Randall F (2010) Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles. Int J Mol Med 26:121-5
Najdi, R; Syed, A; Arce, L et al. (2009) A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer. Oncogene 28:4133-46
Nguyen, Anthony V; Martinez, Micaela; Stamos, Michael J et al. (2009) Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 1:25-37
Gatcliffe, T A; Monk, B J; Planutis, K et al. (2008) Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 18:954-62
Hope, Christopher; Planutis, Kestutis; Planutiene, Marina et al. (2008) Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res 52 Suppl 1:S52-61
Planutis, Kestutis; Planutiene, Marina; Moyer, Mary Pat et al. (2007) Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC Cell Biol 8:12
Zell, Jason A; Ignatenko, Natalia A; Yerushalmi, Hagit F et al. (2007) Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int J Cancer 120:459-68

Showing the most recent 10 out of 15 publications